ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021Accesswire • 03/17/21
ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform TechnologyAccesswire • 01/13/21
ENDRA Life Sciences to Present at H.C. Wainwright Virtual BioConnect 2021 ConferenceAccesswire • 01/08/21
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in TissueAccesswire • 12/23/20
ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment OptionAccesswire • 12/18/20
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/17/20
ENDRA Life Sciences Inc.'s (NDRA) CEO Francois Michelon on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/17/20
ENDRA Life Sciences' NASH Test Device, TAEUS, At Commercialization Inflection PointSeeking Alpha • 06/20/20
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/16/20
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/27/20
ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19
ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/10/19
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/15/19